Alexander Lukez

Statistics

Publications

Citations

664

H-Index

Active since

2015

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Northside Hospital

Beth Israel Deaconess Medical Center

Alexander Lukez is an author at Dana-Farber Cancer Institute specializing in immunotherapy after transplantation, hematopoietic stem cell transplantation immunotherapy, and immunotherapy.

ORCID

Publications per year

2015–2016

Publications

Ipilimumab for Patients with Relapse after Allogeneic Transplantation

Matthew S. Davids, Haesook T. Kim, Pavan Bachireddy et al. · New England Journal of Medicine · 2016 · 594 citations · Full text

Medicine, Immunology, Oncology +15

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

Shernan G. Holtan, Nandita Khera, John E. Levine et al. · Blood · 2016 · 59 citations · Full text

Life Sciences, Clinical Sciences, Surgery +15

A Multicenter Phase I/Ib Study of Ipilimumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation

Matthew S. Davids, Haesook T. Kim, Caitlin Costello et al. · Blood · 2015 · 11 citations

Medicine, Hematology, Oncology +14

1–3 of 3